EQRx, a new pharmaceutical startup from biotech entrepreneur Alexis Borisy, wants to make drugs faster and cheaper than traditional pharma companies.
A Pharma Startup Launches With $200 Million In Funding And A Strategy To Make Drugs Faster, Cheaper
EQRx, a new pharmaceutical startup from biotech entrepreneur Alexis Borisy, wants to make drugs faster and cheaper than traditional pharma companies.